"Lymph Node Excision" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966)
| Descriptor ID |
D008197
|
| MeSH Number(s) |
E04.446
|
| Concept/Terms |
Lymph Node Excision- Lymph Node Excision
- Excision, Lymph Node
- Excisions, Lymph Node
- Lymph Node Excisions
- Lymphadenectomy
- Lymphadenectomies
Lymph Node Dissection- Lymph Node Dissection
- Dissection, Lymph Node
- Dissections, Lymph Node
- Lymph Node Dissections
- Node Dissection, Lymph
- Node Dissections, Lymph
|
Below are MeSH descriptors whose meaning is more general than "Lymph Node Excision".
Below are MeSH descriptors whose meaning is more specific than "Lymph Node Excision".
This graph shows the total number of publications written about "Lymph Node Excision" by people in this website by year, and whether "Lymph Node Excision" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 4 | 4 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 2 | 4 | 6 |
| 2005 | 3 | 3 | 6 |
| 2006 | 4 | 5 | 9 |
| 2007 | 1 | 3 | 4 |
| 2008 | 3 | 0 | 3 |
| 2009 | 2 | 5 | 7 |
| 2010 | 5 | 3 | 8 |
| 2011 | 1 | 6 | 7 |
| 2012 | 4 | 3 | 7 |
| 2013 | 1 | 3 | 4 |
| 2014 | 1 | 4 | 5 |
| 2015 | 2 | 3 | 5 |
| 2016 | 2 | 3 | 5 |
| 2017 | 3 | 10 | 13 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 5 | 7 |
| 2020 | 2 | 4 | 6 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 2 | 2 |
| 2023 | 1 | 2 | 3 |
| 2024 | 3 | 1 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymph Node Excision" by people in Profiles.
-
Risk of Surgical Overtreatment in cN1 Breast Cancer Patients who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD. Ann Surg Oncol. 2025 Mar; 32(3):2023-2028.
-
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study. J Clin Oncol. 2025 Mar; 43(7):810-820.
-
Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2025 Feb; 32(2):922-930.
-
Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Ann Surg Oncol. 2025 Jan; 32(1):84-91.
-
Optimised treatment of patients with enlarged lateral lymph nodes in rectal cancer: protocol of an international, multicentre, prospective registration study after extensive multidisciplinary training (LaNoReC). BMJ Open. 2024 10 16; 14(10):e083225.
-
Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer. N Engl J Med. 2024 Oct 03; 391(13):1206-1216.
-
Financial toxicity in breast cancer patients receiving regional nodal irradiation: Variation by cancer subtype. Breast. 2024 Dec; 78:103813.
-
Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study. Eur J Cancer. 2024 Nov; 211:114310.
-
Geographic and racial disparities in the quality of surgical care among patients with nonmetastatic uterine cancer. Am J Obstet Gynecol. 2025 Mar; 232(3):308.e1-308.e15.
-
Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2024 Dec; 31(13):8795-8801.